Bardoxolone Methyl Evaluation in Patients With Pulmonary Hypertension (PH) - LARIAT
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 166 participants.
Also called NCT02036970
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 166 participants
- Sponsor
- Registry
-
NCT02036970
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Germany
- Registry status
- Completed
Technical summary
Registry record NCT02036970. Randomized; double masking; primary purpose treatment. Start 2014-05-31 (actual); primary completion 2018-01-19 (actual). Results posted on 2021-07-23.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Bardoxolone Methyl Evaluation in Patients With Pulmonary Hypertension (PH) - LARIAT
- Condition
- Pulmonary Arterial Hypertension
- Condition
- Pulmonary Hypertension
- Condition
- Interstitial Lung Disease
- Condition
- Idiopathic Interstitial Pneumonia
- Condition
- Idiopathic Pulmonary Fibrosis
- Condition
- Sarcoidosis
- Condition
- Respiratory Bronchiolitis Associated Interstitial Lung Disease
- Condition
- Desquamative Interstitial Pneumonia
- Condition
- Cryptogenic Organizing Pneumonia
- Condition
- Acute Interstitial Pneumonitis
- Condition
- Idiopathic Lymphoid Interstitial Pneumonia
- Condition
- Idiopathic Pleuroparenchymal Fibroelastosis
- Intervention (Drug)
- Bardoxolone methyl
- Intervention (Drug)
- Placebo
- Lead sponsor
- Biogen
Record details
- Record id
cardio:ct-nct02036970- Content hash
5a4c3b20db7ac6f1aac76c385a7d31ca198d19cc6461cdf14faf37b205c5764c